RxDoctor Payments Data

Timothy Rocklein, PA

Medical · Sarasota, FLNPI 1538407846

Payments from drug & device makers

$835in general payments, 2019–2025

Across 55 payments — averaging $15.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$349
  • Scilex Pharmaceuticals Inc.$148
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$74
  • Azurity Pharmaceuticals, Inc.$52
  • Averitas Pharma Inc.$30
  • IBSA Pharma Inc.$28
  • plus $153 from 7 others

What the payments were for

  • Food & beverage$835100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$835 in reported general payments places this provider in the 50th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$164,313
Medicare patients
175
Services billed
2,232

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl49$36,460
RelistorMethylnaltrexone Bromide12$34,180
LinzessLinaclotide49$29,790
Xtampza ErOxycodone Myristate63$25,429
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen757$25,134
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen652$19,242
MovantikNaloxegol Oxalate35$16,010
ZtlidoLidocaine15$11,298
ButransBuprenorphine19$10,249
Buprenorphine37$8,885
Gabapentin602$7,198
Lidocaine73$7,169
Oxycodone Hcl408$6,653
OxycontinOxycodone Hcl12$6,075
Diclofenac Potassium27$5,098

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er$349$61,888112 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$74$34,18012 claims
Scilex Pharmaceuticals Inc.Ztlido$148$11,29815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,031 medical providers in Florida.

Other medical in Sarasota

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →